Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...

Though David says his ankle weights warmup is “unscientific” and does not recommend this practice to the athletes he coaches, ...

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...

Quantum Strategy's David Roche says Europe's defense spending needs to increase by at least $200 billion as he discusses the ...

Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...

Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...

BanyanGlobal Family Business Advisors announced that Stephan Roche, former CEO of Walton Enterprises and COO of Cascade Asset Management – the ...

Roche's Q4 results and innovative advancements make it a strong pick. Its late-stage pipeline supports our belief that there ...

Genentech, a member of the Roche Group, announced new positive data from Stage 2 and Stage 3 of the National Institutes of Health-sponsored Phase III OUtMATCH study, which provide ...

The value that laboratories contribute to clinical decision-making is critical to the future of health care and enables ...

Posay, the dermatologist-recommended leader in skincare, is thrilled to announce its partnership with the BNP Paribas Open as ...